JENBURKT PHARMACEUTICALS
Back to Balance Sheet
|
JENBURKT PHARMACEUTICALS Last 5 Year Total Liabilities History
[Standalone]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Liabilities | ₹195 Cr | ₹164 Cr | ₹141 Cr | ₹143 Cr | ₹120 Cr |
What is the latest Total Liabilities ratio of JENBURKT PHARMACEUTICALS ?
Year | Total Liabilities |
---|---|
Mar2025 | ₹195 Cr |
Mar2024 | ₹164 Cr |
Mar2023 | ₹141 Cr |
Mar2022 | ₹143 Cr |
Mar2021 | ₹120 Cr |
How is Total Liabilities of JENBURKT PHARMACEUTICALS Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹195 Cr | 18.51 | |
Mar2024 | ₹164 Cr | 16.21 | |
Mar2023 | ₹141 Cr | -0.84 | |
Mar2022 | ₹143 Cr | 18.38 | |
Mar2021 | ₹120 Cr | - |
Compare Total Liabilities of peers of JENBURKT PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
JENBURKT PHARMACEUTICALS | ₹587.7 Cr | -0.5% | -1.3% | 40.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹416,273.0 Cr | 2.5% | 4.1% | -0.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹176,604.0 Cr | 0.5% | -2.9% | 35.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹126,316.0 Cr | 6.2% | 9.3% | 17.9% | Stock Analytics | |
CIPLA | ₹125,993.0 Cr | 4.9% | 2.9% | 1.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹107,795.0 Cr | 2.1% | 1.2% | -5% | Stock Analytics |
JENBURKT PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
JENBURKT PHARMACEUTICALS | -0.5% |
-1.3% |
40.1% |
SENSEX | -1.5% |
-2.5% |
0.2% |
You may also like the below Video Courses